BE 4.0 Industries of the Future 2022 Show – Mulhouse
R&D Technology and JBT HubUp announce a unique partnership agreement for the development and custom manufacturing of innovative medical devices.
This unique national alliance, covering the whole country, represents a turnover of 100 million euros with 11 production sites throughout the world and 3000 m² of clean rooms. With more than 850 employees, these seven key players cover all the skills needed to accelerate and succeed in the development of innovative medical devices.
Depending on the project and the skills required, these companies can count on the recognised experience of each of the partners, namely in plastic injection and mould manufacturing (JBT Group), in design and registration of medical devices (Opia Technologies), in industrialisation expertise and project management (Sibaya BCPharMed), in the design and construction of automated machines and production facilities (RDPM and ICM), in design and development of fluidic devices and components (EVEON), and in LSR silicone injection (Progress).
“We want to offer our customers the creation of this collective intelligence so that together we can overcome the challenges of tomorrow's health. It is also the beginning of a beautiful human and technological adventure.”
Bruno COCHETEUX | CEO of JBT HubUp
JBT HubUp is comprised of customer-focused companies of various sizes, eager to provide solutions to facilitate and accelerate the market launch of products. After identifying the required partners for a project, a single contact person is appointed to take charge of the relationship with the client. This contact person understands all the customer’s issues, from the design phase to the industrialisation and automation of the assembly. He/she coordinates all the partners who are committed, in a team spirit, to the values of loyalty and responsibility towards customers and suppliers.
R&D Technology specialises in the design and manufacture of automated and/or robotised production equipment and brings its expertise in industrialisation to guide the technical and technological choices made at the design stage of the device, with the aim of ensuring optimum productivity for the assembly, packaging and wrapping machines produced subsequently.
For medical devices requiring specific equipment for their use, R&D Technology offers its NOVACT service, which covers all stages of development, from design to prototyping and testing to series production. “The synergy and complementarity between all the JBT HubUp partners are a formidable catalyst for this extraordinary alliance,” explains Philippe Roser, CEO of R&D Technology.
JBT HubUP is a company and an alliance of entrepreneurs that offers the pharmaceutical and medical industry a unique solution for the development of innovative medical devices by bringing together, from the very beginning of the project, the business skills necessary to achieve all the objectives: from design to qualification, through component manufacturing and assembly.
This alliance represents more than 850 employees spread over 11 production sites worldwide, with 3,000 m² of clean rooms and a turnover of 100 million euros. The development team consists of approximately 80 engineers and 20 project managers.